DOMT Betweenincrease "EPS" and increase in volumeOn a specialized economic level, after reviewing the financial statements for the first quarter of the stock, the increase in the number of shares was marginal (in the millions) and the increase in earnings per share was also by a fraction of a penny. However, on a technical analysis level of the volume, a state of stability and exchange of shares in large quantities ("accumulation") is evident without any increase in the stock price. In other words, the chart shows us that there are accumulation operations for a full session without including holidays, especially after the last cash dividend distribution from the stock. This operation makes us wait for a strong upward movement for the stock to return to the levels of 14 Egyptian pounds during June. The stock will recover, and it is a great opportunity to achieve no less than 20% on investing in this stock. This is not advice, but an analysis. I believe that the second quarter results will be higher because the month of Ramadan, which was between March and April, disrupts a large part of the revenue from Suntech Dmetty's sales. We will notice high semi-annual statements at a high rate.
Please note that this is a direct translation and does not include any additional information or interpretations
Atumra
Egyptian Drug Authority and Pharmaceutical CompaniesEbeco Company is one of the leading pharmaceutical companies in Egypt, with a long history of manufacturing and exporting medicines. Over the past two years, the company has benefited from therapeutic supply contracts to African countries through the United Nations and the African Union, which has led to significant growth in its revenues and profits.
Negative Impacts:
However, the company has faced some challenges in the Egyptian market over the past seven months due to the implementation of maximum price caps for medicines by the Egyptian Drug Authority. This decision has particularly affected Ebeco, as most of its profitable medicines are antibiotics and cough syrups, which are categories of medicines that have been included in the price cap.
Positive Impacts:
Despite these challenges, Ebeco has been able to compensate for some of its losses by expanding its operations into Central African markets through international export companies.
Short-Term Outlook:
In the short term, Ebeco's share price is expected to move in a trading range between 32 and 48 Egyptian pounds. This is due to investors waiting for the Egyptian Drug Authority's approval of requests from pharmaceutical companies to raise their prices.
Future Scenarios:
In case of approval to raise prices:
Share prices of all pharmaceutical companies are expected to rise significantly, in line with the percentage allowed for price increases.
This will lead to an improvement in Ebeco's financial performance and attract more investors to the stock.
In case of rejection by the Egyptian Drug Authority of requests to raise prices:
The scenario of a decline in the share price and a continued trading range is likely to continue until a new development occurs.
The company may face further challenges in the Egyptian market, which could negatively impact its financial performance.
Obour Land for Food Industries (OLFI) Four next 6 MonthOver the past months, the stock has experienced a decline after it showed growth and a decline in its p/e from 9 to 7, and this should have been reflected in the price, but it was much lower.
What happened was 3 years ago
The pound's concerns faded against the US dollar
Customs release
The distribution of good profits is 0.95 piasters
During the coming period, we notice the following: First, there will be a rise in the resistance levels, which are represented by 9 pounds.
If he breaks it, we will go to 9.5, and then 10 to 12 to 14 pounds for sure.
We expect success for everyone
ZMID Zahraa Maadi Investment & DevelopmentThe stock has an imaginary support level at 5 Egyptian pounds and is currently trading in a resistance range between 6.30 and 6.5 Egyptian pounds, forming a flag pattern. If it breaks above the 6.70 Egyptian pound level during any weekly session, it could reach 7 Egyptian pounds, followed by 7.2 Egyptian pounds, 7.5 Egyptian pounds, and eventually 8 Egyptian pounds. Coincidentally, the company will be implementing decisions made at the company's general meeting after approving the distribution of dividends of 0.15 Egyptian pounds divided into two installments, as well as the distribution of free shares in August. This will likely cause the stock to fall again to half its price, reaching levels of 4 Egyptian pounds. This will create a new bottom for the stock, but remember that you will not have lost money; instead, you will have received free shares.